| abstract |
The present invention relates to a process for the bonding and conversion of carbonyl compounds to the diisulfide compound, which is thus reacted with a 1,2,4-thiadiazole ring system of the general formula (I) which is substituted at position 3 and terminated in position 3 of the thiadiazole ring. . Processes include, but are not limited to, pharmaceutical-grade enzymes for therapeutic purposes, such as inhibition of H + / K + -ATPase (gummy suppository) or removal of industrial target compounds from gas or masterbatch mixtures. The thiadiazole compounds used in the process of the invention are partial, and the present invention also relates to these compounds. ŕ |